FDA
-
-
-
-
-
-
-
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
-
-
-
-
-
-
-
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
-
-
-
-
-
-
-
Vericel (VCEL) Announces FDA Approval and Commercial Availability of MACI Arthro
-
-
-
-
-
-
-
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
-
-
-
-
-
-
-
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
-
-
-
-
-
-
-
Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program
-
-
-
-
-
-
-
Vericel Reports Third Quarter 2022 Financial Results
-
323,560 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

